Cargando…
Vericiguat in combination with isosorbide mononitrate in patients with chronic coronary syndromes: The randomized, phase Ib, VISOR study
Vericiguat was developed for the treatment of symptomatic chronic heart failure (HF) in adult patients with reduced ejection fraction who are stabilized after a recent decompensation event. Guidelines recommend long‐acting nitrates, such as isosorbide mononitrate, for angina prophylaxis in chronic c...
Autores principales: | Boettcher, Michael, Mikus, Gerd, Trenk, Dietmar, Düngen, Hans‐Dirk, Donath, Frank, Werner, Nikos, Karakas, Mahir, Besche, Nina, Schulz‐Burck, Dominik, Gerrits, Mireille, Hung, James, Becker, Corina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099120/ https://www.ncbi.nlm.nih.gov/pubmed/35299288 http://dx.doi.org/10.1111/cts.13238 |
Ejemplares similares
-
Vericiguat in Combination with Short‐Acting Nitroglycerin in Patients With Chronic Coronary Syndromes: The Randomized, Phase Ib, VENICE Study
por: Boettcher, Michael, et al.
Publicado: (2022) -
Vericiguat: A Randomized, Phase Ib, Placebo-Controlled, Double-Blind, QTc Interval Study in Patients with Chronic Coronary Syndromes
por: Böttcher, Michael, et al.
Publicado: (2023) -
Isosorbide mononitrate promotes angiogenesis in embryonic development
of zebrafish
por: Lv, Hui, et al.
Publicado: (2020) -
Pharmacodynamic and Pharmacokinetic Interaction Profile of Vericiguat: Results from Three Randomized Phase I Studies in Healthy Volunteers
por: Boettcher, Michael, et al.
Publicado: (2020) -
Management of Massive Rivaroxaban Overdose With Acetaminophen and Isosorbide Mononitrate Overdose
por: Casey, Bradley, et al.
Publicado: (2023)